Mechanism of Action of PRMs (Progesterone Receptor Modulators) as a basis for new therapies targeting chronic debilitating women's health disorders

Trial Profile

Mechanism of Action of PRMs (Progesterone Receptor Modulators) as a basis for new therapies targeting chronic debilitating women's health disorders

Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Jun 2016

At a glance

  • Drugs Ulipristal (Primary)
  • Indications Uterine leiomyoma
  • Focus Pharmacodynamics
  • Most Recent Events

    • 08 May 2014 Planned End Date changed from 14 Feb 2014 to 31 Jan 2014 as reported by United Kingdom Clinical Research Network record.
    • 08 May 2014 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network record.
    • 16 Feb 2014 Accrual to date is 100% according to United Kingdom Clinical Research Network.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top